Overexpression of MDM2 was frequently observed in various types of cancers, such as osteosarcoma, rhabdomyosarcoma, and fibrosarcoma,21, 22 and it was usually associated with poor prognosis. This evidence concerns the gene MDM2 and fibrosarcoma.